Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 15:11:1269393.
doi: 10.3389/fpubh.2023.1269393. eCollection 2023.

Knowledge is power? Cervical cancer prevention in female OB/GYNs compared to other female physicians

Affiliations

Knowledge is power? Cervical cancer prevention in female OB/GYNs compared to other female physicians

Gal Hershkovitz et al. Front Public Health. .

Abstract

Cervical cancer (CC) screening and prevention are crucial responsibilities of obstetrician-gynecologists (OB/GYNs). Our study aimed to investigate whether knowledge impacts OB/GYNs' (n = 42) adherence to CC prevention measures by comparing them to non-OB/GYN physicians (n = 80). An anonymous questionnaire collected demographic information, personal screening habits and evaluated their knowledge of CC prevention. Results revealed that OB/GYNs exhibited superior knowledge of CC risk factors and prevention compared to non-OB/GYNs. Of note, a lower percentage of OB/GYN residents correctly identified the recommended upper age limit for cervical screening and for HPV vaccination compared to attending OB/GYNs (50% vs. 83%, p = 0.04 and 11% vs. 50%, p = 0.01, respectively). Despite these findings, most physicians from both groups recommended HPV vaccination. Cervical screening rates were similar between OB/GYNs and non-OB/GYNs (75% vs. 83%, p = 0.3). Half of OB/GYNs initiated their own cervical screening, similar to non-OB/GYNs. Interestingly, residents had higher HPV vaccination rates compared to attending physicians, irrespective of specialty (OB/GYNs - 38.89% vs. 4.76%, p = 0.0149; non-OB/GYNs - 51.06% vs. 15.38%, p = 0.0028). In conclusion, contrary to the assumption that physicians prioritize personal well-being, our study reveals the opposite. While skilled in guiding patients through CC screening and prevention, female OB/GYNs often neglect their own health. OB/GYNs must also be educated and supported in safeguarding their health, setting an essential example for patients.

Keywords: HPV vaccine; OB/GYN; cervical cancer; cervical screening; female physicians; prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Pie chart presentation of seniority for OB/GYN (right panel) and non-OB/GYN (left panel) in the study cohort. R – residents, AP − attending physician. (B) Pie chart presentation of specialty distribution of non-OB/GYN in the study cohort. R − residents, AP − attending physician, ICU − intensive care unit, ER − emergency room. Of non-OB/GYN residents: Oncology − 2.08%, Hematology − 4.17%, Anesthesiology − 25%, ICU − 6.25%, Pediatrics − 18.75%, General surgery − 8.33%, Plastic surgery − 2.08%, Internal medicine − 22.93%, Rheumatology − 2.08%, Radiology − 8.33%. Of non-OB/GYN attending physicians: Oncology − 12.5%, Gastroenterology − 3.125%, Hematology − 9.375%, Anesthesiology − 12.5, %, ICU − 9.375%, Pediatrics − 18.75%, Dermatology − 3.125%, Ophthalmology − 3.125%, Internal medicine − 12.5%, Psychiatry − 3.125%. Rheumatology − 9.375%, Radiology − 3.125%.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2021) 71:209–49. doi: 10.3322/caac.21660, PMID: - DOI - PubMed
    1. Hull R, Mbele M, Makhafola T, Hicks C, Wang S‑M, Reis R, et al. . Cervical cancer in low and middle-income countries. Oncol Lett. (2020) 20:2058–74. doi: 10.3892/ol.2020.11754, PMID: - DOI - PMC - PubMed
    1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. (1999) 189:12–9. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F - DOI - PubMed
    1. Berrington de González A, Green J, I.C.O.E.S.O.C . Cancer, comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. (2007) 120:885–91. doi: 10.1002/ijc.22357 - DOI - PubMed
    1. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. . Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical Cancer elimination initiative. Lancet Glob Health. (2023) 11:e197–206. doi: 10.1016/S2214-109X(22)00501-0, PMID: - DOI - PMC - PubMed

MeSH terms